E-MAIL UPDATES

Click here to join

At the cutting edge

At the
cutting edge.

Research for life

Research
for life.

Innovation and performance

Innovation and
performance.

Latest

What's new.

For a copy of this analyst report please contact your Maxim analyst Jason McCarthy - jmccarthy@maximgrp.com

August 2nd 2022
analyst reports

August 1st 2022
analyst reports

For a copy of this research report please contact your Ladenburg advisor.

August 1st 2022
analyst reports

August 1st 2022
press releases

July 28th 2022
press releases

For a copy of this analyst report please contact your Jefferies advisor.

July 22nd 2022
analyst reports
more

Upcoming Events

What's next.

September 20th 2022 - September 22nd 2022

read more
September 28th 2022

read more
September 29th 2022

read more

Who we are

About us.

passion.

It takes a great deal of passion to pursue the fight against cancer and autoimmune diseases. We put our heart and soul into winning it.

know-how.

Our goal is to gather the strongest forces, the brightest minds and the most dedicated employees.

research.

Accurate research and development is the strongest foundation for developing effective treatments.

What is LAG-3?
Lymphocyte-activation gene 3, or LAG-3 (LAG-3), is a gene that provides the genetic information to make a cell surface molecule with biologic effects on T cell function.
LAG-3 is being used for many immunotherapy treatments including Eftilagimod Alpha from Immutep.